The company-creation health fund
W Health Ventures is a healthcare company-creation fund based in Mumbai. Unlike traditional venture capital, which picks from existing startups, WHV starts from pre-idea: it identifies white spaces in healthcare, researches the problem for a year or more, assembles founding teams, and builds companies from scratch to category leadership — in India and across the US-India corridor. Its purpose, in its own words, is to solve what stands between a billion people and better health. Its official site states it has deployed over $65 million across 14 portfolio companies, with 100% of them raising downstream capital and reaching more than 25 million patients.
Investment thesis
WHV's thesis is that India's healthcare system sits at an inflection point: rising demand and constrained supply create a structural mismatch, and the most valuable businesses will be built where that mismatch is highest. It backs single-specialty care platforms in India and AI-enabled B2B healthcare services for global companies. A 50-member in-house team of physicians, operators and technologists hunts for clinical and operational white spaces before a company is even founded — a model managing partner Pankaj Jethwani likens to using international markets as a 'time machine' for healthcare innovation.
Sectors and stages
The firm builds healthcare companies exclusively, from pre-idea inception through growth. Fund II concentrates on single-specialty care platforms in India and AI-enabled business-to-business healthcare services for global companies. It typically builds 8–10 companies per fund over about four years, committing ₹30–50 crore per incubation.
Fund size and cheque sizes
Fund II closed in September 2026 at ₹700 crore (about $74.1 million), exceeding its ₹630 crore target after an initial close of ₹550 crore earlier in the year. Fund I invested in more than 12 startups. Typical deployment is ₹30–50 crore per company across two to three startups each year.
Notable portfolio
Fund I companies include Nivaan (interventional chronic-pain clinics), BeatO (diabetes care), Elevate Now (doctor-led obesity and GLP-1 programmes), BabyMD (paediatrics, now part of Hoola Health's child-first clinic model), and Mylo (parenting support), alongside cross-border companies Wysa (AI mental-health services) and Reveal HealthTech (AI transformation services) — all of which raised external growth capital. Fund II's first two companies are Everhope Oncology, building a world-class cancer-care institution in India, and Everbright Health, bringing advanced psychiatry treatments to US practices.
Partners and team
The firm is led by managing partner Pankaj Jethwani, supported by a 50-strong in-house platform team of physicians, operators and technologists. It has offices in Mumbai, Bengaluru, Delhi and Boston.
Programs, accelerators and perks
W Health Ventures runs no publicly documented accelerator or fellowship programme separate from its company-creation model, and there are no publicly documented startup credits or perks. Its platform — shared playbooks, partnerships and the in-house clinical-operating team — functions as the equivalent of an internal accelerator for the companies it builds.
Why it matters for founders
W Health Ventures is not a fund to pitch with a deck — it is a fund to build with. If you are a clinician, operator or technologist obsessed with a white space in healthcare delivery, WHV will co-found the company from pre-idea, fund it with ₹30–50 crore, and surround it with physicians, operators and shared playbooks. With Fund II's ₹700 crore freshly closed and its first two companies in oncology and psychiatry, now is the moment to bring them a problem worth solving.